Mammalian Cell Culture, Monoclonal Antibodies and Recombinant Proteins
DSM Biologics, a unit of DSM Pharmaceutical Products, is a leading provider of
manufacturing technology and services to the biopharmaceutical industry. In
addition to offering world-class manufacturing services, DSM Biologics has
coexclusive rights, along with Dutch biotech company Crucell N.V., to license
the high-producing PER.C6® human cell line as a production platform for
recombinant proteins and monoclonal antibodies. DSM Biologics’ FDA-approved
facility in Groningen, The Netherlands was established in 1986, and has a
strong track record for using a broad range of cell lines (PER.C6®, CHO,
hybridoma, etc.) in biopharmaceutical manufacturing. In addition, this site
has a wide range of experience using multiple manufacturing (batch, fed-batch
and continuous perfusion) and purification techniques.
The combination of the PER.C6® human cell line with DSM’s manufacturing
services provides companies with a turn-key biologic manufacturing solution
that reduces cost, risk and time to market.
Whether you’re poised for preclinical development, clinical trials or
commercial production, our staff of scientists and researchers can utilize our
manufacturing facilities to bring your project from concept to completion
successfully, and ahead of the competition.
